Qube Research & Technologies (QRT)’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.91M Buy
283,033
+198,449
+235% +$6.25M 0.01% 1346
2025
Q4
$2.49M Buy
84,584
+17,792
+27% +$494K ﹤0.01% 2162
2025
Q3
$1.69M Buy
+66,792
New +$1.63M ﹤0.01% 2310
2024
Q1
Sell
-250,547
Closed -$7.17M 4821
2023
Q4
$7.17M Buy
250,547
+149,009
+147% +$4.38M 0.01% 870
2023
Q3
$3.76M Sell
101,538
-8,071
-7% -$308K 0.01% 1072
2023
Q2
$4.28M Sell
109,609
-204,499
-65% -$8.01M 0.02% 740
2023
Q1
$11.5M Buy
+314,108
New +$9.91M 0.05% 428

Other funds holding RTO

Qube Research & Technologies (QRT)'s RTO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Rentokil (RTO) stake by 235% in Q1 2026, buying an estimated $6.25M and bringing the position to 283,033 shares worth $8.91M. The position accounts for 0.01% of the portfolio, ranked #1346.

Qube Research & Technologies (QRT) first reported a position in RTO in Q1 2023 and has held it in 7 quarters since. The position peaked at $11.5M in Q1 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Qube Research & Technologies (QRT) held 283,033 shares of Rentokil worth $8.91M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 198,449 Rentokil shares in Q1 2026, an estimated $6.25M.
  • Rentokil made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1346 holding.
  • Qube Research & Technologies (QRT) first reported a position in Rentokil in Q1 2023 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Rentokil position peaked at $11.5M in Q1 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.